Care TwentyoneTSE:2373 +0.24%61 EBITDA Margin % is 2.42% as of Apr. 2026, which is 68% below its 10-year median of 7.65. GuruFocus rates TSE:2373 with a GF Score™ of 61/100 and a GF Value™ of 円478.53 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Care Twentyone ranks worse than 66.02% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Care Twentyone's EBITDA for the
six
months ended in Apr. 2026 was 円600 Mil. Care Twentyone's Revenue for the
six
months ended in Apr. 2026 was 円24,803 Mil. Therefore, Care Twentyone's EBITDA margin for the quarter that ended in Apr. 2026 was 2.42%.
Care Twentyone (TSE:2373) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Care Twentyone EBITDA Margin % Related Terms
Care Twentyone EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Care Twentyone's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2373 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Care Twentyone's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Care Twentyone EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Care Twentyone's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Care Twentyone's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Care Twentyone (TSE:2373) has a EBITDA Margin % of 2.42% as of Apr. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Care Twentyone and its competitors. This is 68% below median its historical median of 7.65. Over the past decade, Care Twentyone's EBITDA Margin % has ranged from 3.49 to 9.71. According to the industry distribution chart, Care Twentyone ranks #441 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 66%.
Is Care Twentyone's EBITDA Margin % too high?
Care Twentyone's current EBITDA Margin % of 2.42% is 68% below median its 10-year median of 7.65. Over the past 10 years, this metric has ranged from a low of 3.49 to a high of 9.71. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Care Twentyone's value of 2.42% is 76.3% below this industry median. Based on the distribution chart, Care Twentyone ranks #441 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Care Twentyone has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Care Twentyone's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Care Twentyone ranks #441 out of 668 companies for EBITDA Margin %. This places Care Twentyone in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Care Twentyone's value of 2.42% is 76.3% below this benchmark. Historically, Care Twentyone's own EBITDA Margin % has ranged from 3.49 to 9.71 over the past decade. While the company's 10-year median is 7.65 vs. the industry median of 10.21, Care Twentyone has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Care Twentyone's current EBITDA Margin % of 2.42% is 76.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Care Twentyone and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Care Twentyone's current EBITDA Margin % is 2.42%, which is 68% below median its own 10-year median of 7.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Care Twentyone stock overvalued right now?
Based on GuruFocus' analysis, Care Twentyone (TSE:2373) is currently considered Modestly Undervalued. The stock's GF Value™ is 円478.53, compared to a current price of 円410.00 — trading 14.3% below its estimated fair value. The current EBITDA Margin % is 2.42%, which is 68% below median its 10-year median of 7.65 and 76.3% below the Healthcare Providers & Services industry median of 10.21. Care Twentyone's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Care Twentyone (TSE:2373), the current EBITDA Margin % is 2.42% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Care Twentyone (TSE:2373) Overvalued in 2026?
Based on GuruFocus' analysis, Care Twentyone stock appears to be undervalued.
The current stock price of 円410.00 is trading 14.3% below its estimated GF Value™ of 円478.53.
GuruFocus considers Care Twentyone to be Modestly Undervalued.
Key valuation signals for TSE:2373:
EBITDA Margin %: 2.42% (68% below median its 10-year median of 7.65)
GF Value™: 円478.53 vs. price of 円410.00 (14.3% below fair value)
Industry Position: 76.3% below the Healthcare Providers & Services median (#441 of 668)
No single metric tells the full story. See the TSE:2373 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Care Twentyone Corp provides nursing care services. It also leases and sells nursing equipment as well as operates a nursing home for the elder people. It also provides daycare homes, nursing homes, and group homes. It is also engaged in small-scale multifunctional home care, welfare equipment sales, rental and housing repair and light work contracting business. The company has two reportable segments based on its business model: In-home nursing care business; and Facility-based nursing care business. The home care business provides visiting care services, home care support services, day care services, etc. The Facility-based Nursing Care Business operates paid nursing homes and group homes.
61GF Score
Get the complete analysis for TSE:2373
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2373 has been successfully added to your 
